My WebMD Sign In

Please enter email address

Enter your password

Keep me signed in on this computer

Show more Information

If you select "Keep me signed in on this computer", you can stay signed in to WebMD.com on this computer for up to 2 weeks or until you sign out. This means that a cookie will stay on your computer even when you exit or close your browser which may reduce your levels of privacy and security. You should never select this option if you're using a publicly accessible computer, or if you're sharing a computer with others. Even if you select this option there are some features of our site that still require you to log in for privacy reasons.

Forget your password? Having trouble signing in?

Why should I
sign up for WebMD?

With a WebMD Account you can:

Track your way to weight loss success
Manage your family's vaccinations
Join the conversation

See more benefits Sign Up

Why WebMD?

My WebMD

Show Menu

Facebook Twitter Pinterest

WebMD Home

Cancer Health Center

Cancer Related Topics

Email a Friend

Print Article

Cancer Health Center

Tools & Resources

Font Size

To Learn More About Melanoma

For more information from the National Cancer Institute about melanoma, see the following:

Melanoma Home Page
What You Need to Know About™ Melanoma
What You Need to Know About™ Moles and Dysplastic Nevi
Skin Cancer Prevention
Skin Cancer Screening
Biological Therapies for Cancer: Questions and Answers
Sentinel Lymph Node Biopsy: Questions and Answers
Advances in Targeted Therapies

For general cancer information and other resources from the National Cancer Institute, see the following:

Recommended Related to Cancer

Recurrent or Chemoresistant Gestational Trophoblastic Tumor Treatment

Recurrent disease indicates failure of prior chemotherapy unless initial therapy was surgery alone. One study found recurrence of disease in 2.5% of patients with nonmetastatic disease, 3.7% of patients with good-prognosis metastatic disease, and 13% of patients with poor-prognosis metastatic disease.[1] Nearly all recurrences occur within 3 years of remission (85% before 18 months). A patient whose disease progresses after primary surgical therapy is generally treated with single-agent chemotherapy...

Read the Recurrent or Chemoresistant Gestational Trophoblastic Tumor Treatment article > >

What You Need to Know About™ Cancer
Understanding Cancer Series: Cancer
Cancer Staging
Chemotherapy and You: Support for People With Cancer
Radiation Therapy and You: Support for People With Cancer
Coping with Cancer: Supportive and Palliative Care
Cancer Library
Information For Survivors/Caregivers/Advocates

WebMD Public Information from the National Cancer Institute

Last Updated: October 07, 2011

This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information.